ClinicalTrials.gov
ClinicalTrials.gov Menu

Complications: Urgent C Section VS Elective C Section

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01524107
Recruitment Status : Recruiting
First Posted : February 1, 2012
Last Update Posted : December 20, 2016
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The medical literature does not provide sufficient information or recommendation regarding specific antibiotic coverage for urgent Caesarian sections. The goal of this study is to compare maternal and neonatal morbidity of women who have undergone urgent Caesarian Sections for Prolapsed Cord to those who have undergone Elective Caesarian Sections in order to develop a standard treatment protocol. The Medical Record review will include many parameters including complications, type of antibiotic usage etc.

Condition or disease
Urgent Caesarian Section Secondary to Cord Prolapse

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 240 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Comparison of Maternal and Fetal Complications After Urgent Caesarian Section for Prolapsed Cord Versus Elective Caesarian Section.
Study Start Date : January 2012
Estimated Primary Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cesarean Section
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Urgent Caesarian Section
Elective Caesarian Section


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women undergoing Urgent Caesarian Section for Prolapsed Cord and women undergoing Elective Caesarian Section at Hadassah Medical Center-Har HaTzofim.
Criteria

Inclusion Criteria:

  • women undergoing urgent Caesarian Section for Prolapsed Cord.
  • women undergoing Elective Caesarian Section.

Exclusion Criteria:

  • preterm birth
  • multiple gestation
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01524107


Contacts
Contact: Drorith Hochner-Celnikier, MD 00 972 2 5844400 hochner@hadassah.org.il

Locations
Israel
Hadassah Medical Organization Recruiting
Jerusalem, Israel
Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il   
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Drorith Hochner-Celnikier, MD Hadassah Medical Organization
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01524107     History of Changes
Other Study ID Numbers: CSURGENT-ELECT-HMO-CTIL
First Posted: February 1, 2012    Key Record Dates
Last Update Posted: December 20, 2016
Last Verified: December 2016

Keywords provided by Hadassah Medical Organization:
Prophylaxis Antibiotics
Maternal Complications
Neonatal Complications
Cord Prolapse
 Elective Caesarian Section
Maternal Morbidity
Neonatal Morbidity

Additional relevant MeSH terms:
Prolapse
Pathological Conditions, Anatomical